Financial

Caris Life Sciences Publishes npj Precision Oncology Study Showing AI-Guided Therapy Selection is Predictive of Longer Survival in Patients with Pancreatic Cancer

Caris AI Insights for pancreatic cancer is proprietary, only available to Caris Life Sciences customers and not achievable through small...

New PhaseV Survey Reveals 88% of Sponsors Face Five or More Weeks of Delay in Trial Reporting and Data Workflows, Amid Vendor Fragmentation and Repeated Protocol Amendments

Sponsors Report Juggling up to Five Vendors and Four Phase II-III protocol Amendments Per Trial, Fueling Demand for AI-driven AutomationBOSTON,...

error: Content is protected !!